Inzoomen: druk op uw toetsenbord op CtrlCommand + +
Uitzoomen: druk op uw toetsenbord op CtrlCommand + -
Gebruik knijpzoomen om eenvoudig in en uit te zoomen

AGERAGE project

Laatste wijziging: 24 January 2022

AGE mediated RAGE activity:  new target for multiple sclerosis


Principal Investigator: Prof. Dr. Jerome Hendriks, Researcher: Suzanne Wetzels


The purpose of this study is to investigate the role of advanced glycation endproducts (AGE), the precursors of AGEs, methylglyoxal, and the receptor for AGEs (RAGE) in the pathophysiology of multiple sclerosis (MS). Advanced glycation endproducts (AGEs) are glycosylated proteins which originate from a non-enzymatic reaction of reduced sugars with amino acids to proteins through the formation of methylglyoxal. This reaction occurs in the body, but also in food that is heated. AGEs can bind to RAGE and trigger an inflammatory response.


 In this study, plasma/serum, CSF samples and monocytes of MS patients and controls will be used. First, the concentration of AGEs and methylglyoxcal will be measured in the plasma/serum and CSF using ultra performance liquid chromatography tandem mass spectrometry (UPLC-MSMS). Next, the concentration of sRAGE will be determined in the plasma/serum and CSF using ELISA. Finally, peripheral blood mononuclear cells (PBMCs) will be used for FACS analysis and the amount of monocytes will be determined as will the degree of RAGE on these monocytes.